Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: an interspecies model of tumor angiogenesis

References

• Folkman J. Tumor angiogenesis and tissue factor. Nat Med 1996; 2: 209–215
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, et al. Bone marrow angiogenesis and progression in multiple myeloma. British J Haematol 1994; 87: 503–508
   PubMed Web of Science ®Google Scholar
• Ranieri G, Gasparini G. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy. CDT – IEMD 2001; 1: 179–187
   Google Scholar
• Ranieri G, Patruno R, Fiore G, Saponaro G, Paradiso A, Grammatica L. Thymidine Phosphorylase over-expression in oral squamous carcinoma tissue as a potential target of Capecitabine. LDDD 2004; 1: 45–49
   Google Scholar
• Ranieri G, Coviello M, Chiriatti A, Stea B, Montemurro S, Quaranta M, et al. Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls. Oncol Rep 2004; 11: 435–439
   PubMed Web of Science ®Google Scholar
• Polverini P F. How the extracellular matrix and macrophages contribute to angiogenesis-dependent disease. Eur J Cancer 1996; 32: 2430–2437
   Web of Science ®Google Scholar
• Norrby K, Wooley D. Role of mast cells in mitogenesis and angiogenesis in normal tissues and tumor tissue. Adv Biosci 1993; 89: 71–115
   Google Scholar
• Ribatti D, Crivellato E, Candussio L, Vacca A, Nico B, Benagiano V, et al. Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human α-2a interferon and partly mediated by fibroblast growth factor-2′. Haematologica 2002; 87: 465–471
   PubMed Web of Science ®Google Scholar
• Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, et al. Neutrophils as a key cellular target for angiostatin: implication for regulation of angiogenesis and inflammation. FASEB J 2002; 1: 267–269
   Google Scholar
• Gasparini G, Brooks P C, Biganzoli E, Vermeulen P B, Bonoldi E, Dirix L Y, et al. Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 1998; 4: 2625–2634
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Dammacco F. New non-angiogenesis dependent pathways for tumor progression. Eur J Cancer 2003; 39: 1835–1841
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. Eur J Haematol 1996; 56: 45–53, An immunohistochemical and ultrastructural study
   PubMed Web of Science ®Google Scholar
• Bellamy W T. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Semin Oncol 2001; 28: 551–559
   PubMed Web of Science ®Google Scholar
• Stewart M, Talks K, Leek R, Turley H, Pezzella F, Harris H, et al. Expression of angiogenic factors and hypoxia inducible factors HIF-1, HIF-2 and CAIX in non Hodgkin's lymphoma. Histopathology 2002; 40: 253–260
   PubMed Web of Science ®Google Scholar
• Salven P, Teerenhovi L, Joensun H. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma. Blood 1999; 94: 3334–3339
   PubMed Web of Science ®Google Scholar
• Bertolini F, Paolucci M, Peccatori S, Cinieri S, Agazzi A, Ferrucci P F, et al. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol 1999; 106: 504–509
   PubMed Web of Science ®Google Scholar
• Salven P, Orpona A, Teerenhovi L, Joensun H. Simulatenous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non Hodgkin's lymphoma: a single-institution study of 200 patients. Blood 2000; 96: 3712–3718
   PubMed Web of Science ®Google Scholar
• Foss H D, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H. Expression of vascular endothelial growth factor in lymphomas and Castelman's disease. J Pathol 1997; 183: 44–50
   PubMed Web of Science ®Google Scholar
• Hazar B, Paydas Z, Zorludemir S, Sahin S, Tuncer I. Prognostic significance of microvesse density and vascular endothelial growth factor (VEGF) expression in non Hodgkin's lymphoma. Leuk Lymphoma 2003; 44: 2089–2093
   PubMed Web of Science ®Google Scholar
• Bertolini F, Fugetti L, Mancuso P, Gobbi A, Corsini C, Ferrucci P F, et al. Endostatin, an antiangiogenic drug, induces tumor stablization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin's lymphoma. Blood 2000; 96: 282–287
   PubMed Web of Science ®Google Scholar
• Ranieri G, Passantino L, Patruno R, Passantino G, Jirillo F, Catino A, et al. The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol Rep 2003; 10: 1189–1193
   PubMed Web of Science ®Google Scholar
• Restucci B, Maiolino P, Paciello O, Martano M, De Vico G, Papparella S. Evaluation of angiogenesis in canine seminomas by quantitative immunohistochemistry. J Comp Pathol 2003; 128: 252–259
   PubMed Web of Science ®Google Scholar
• Maiolino P, Papparella S, Restucci B, De Vico P. Angiogenesis in squamous cell carcinomas of canine skin: an immunohistochemical and quantitive analysis. J Comp Pathol 2001; 125: 117–121
   PubMed Web of Science ®Google Scholar
• Fournel-Fleury C, Ponce F, Felman P, Blavier A, Bonnefont C, Chabanne L, et al. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Vet Pathol 2002; 39: 92–109
   PubMed Web of Science ®Google Scholar
• Ferre L, Fondeila D, Rabanal R, Ramis A. Detection of T lymphocytes in canine tissue embedded in paraffin wax by means of aniboby to CD-3antigen. J Comp Pathol 1992; 106: 311–314
   PubMed Web of Science ®Google Scholar
• Ranieri G, Gasparini G. Surrogate markers of angiogenesis and metastasis. Metastasis Research Protocols, S A Brooks. Humana Press, Totowa, NJ 2001; 99–114
   Google Scholar
• Weidner N, Semple J P, Welch W R, Folkman J. Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar
• Vermeulen P B, Gasparini G, Fox S B, Colpaert C, Marson L P, Gion M, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002; 38: 1564–1579
   PubMed Web of Science ®Google Scholar
• Ranieri G, Labriola A, Achille G, Florio G, Zito A F, Grammatica A, et al. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int J Oncol 2002; 21: 1317–1323
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Dammacco F. The role of vascular phase in solid tumor growth: a historical review. Neoplasia 1999; 1: 293–302
   PubMedGoogle Scholar
• Ribatti D, Vacca A, Dammacco F, English D. Angiogenesis and anti-angiogenesis in hematological malignancies. J Hematother Stem Cell Res 2003; 12: 11–22
   PubMedGoogle Scholar
• Patnaik A K, Ehler W J, Mac Ewen E G. Canine cutaneous mast cell tumour: morphological grading and survival time in 83 dogs. Vet Pathol 1984; 2: 469–474
   Google Scholar
• Scavelli C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004; 18: 1054–1058
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 1999; 79: 451–455
   PubMed Web of Science ®Google Scholar
• Ranieri G, Vacca A, Di Reda D, Gadaleta-Caldarola G, Franco G, Caloro D, et al. Espressione differenziale di ICAM-1 e LFA-1 nei linfomi non Hodgkin a cellule B. Haematologica 1994; 79: 103–104
   Google Scholar
• Bilalovic N, Blystad A K, Golouh R, Nesland J M, Selak I, Trinh D, et al. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol 2004; 121: 34–42
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L, et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 2000; 85: 171–175
   PubMed Web of Science ®Google Scholar
• Ma Y, Longley B J, Wang X, Blount J L, Langley K, Caughey G H. Clustering of activating mutations in c-kit's juxtamembrane coding region in canine mast cell neoplasm. J Invest Dermatol 1999; 112: 165–170
   PubMed Web of Science ®Google Scholar